Hims & Hers (HIMS) Hits 52-Week High After Earnings
Hims & Hers (HIMS) soars after earnings. Renita Young discuss this as Hims & Hers hit a new 52-week high after earnings.
Hims & Hers' stock jumps on hopes of first profitable year, as it floats opportunities in weight loss
Shares of Hims & Hers Health Inc. rallied after hours on Monday, after the online wellness platform said 2024 would be its first year of positive net income and forecast first-quarter and full-year...
Hims & Hers: Turning The Profitability Corner And Returning 28%
Hims & Hers Health stock has rallied over 50% since our previous "Strong Buy" article, but the stock may be overextended, and earnings are approaching. The company's subscription model, market oppo...
Unlocking Growth: Why Hims & Hers Stock Is A Very Compelling Buy In 2024
Hims & Hers Health is a telehealth company with a unique approach to accessible healthcare solutions. The company operates in a large and diverse TAM, allowing for multiple players to thrive and in...
Where Will Hims & Hers Stock Be in 5 Years?
Hims & Hers aims to destigmatize certain aspects of healthcare while making access to care more convenient. The company's massive growth rate and burgeoning profitability could reward investors ove...
Hims & Hers Health, Inc. (HIMS) Moves 8.3% Higher: Will This Strength Last?
Hims & Hers Health, Inc. (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher i...
Underestimating This Stock Could Be Wall Street's Biggest Mistake in 2024
Analysts believe Hims & Hers Health will lose money in 2024. But comments from the CEO signal this could be wrong.
Hims & Hers Health: Promising Catalysts To Drive Stock Higher
Hims & Hers Health has reported strong quarterly results and improved profits, leading to a stock snapback. The company is moving into AI-based medical services and weight loss management to addres...
Hims & Hers Health Q3: The Cheapest Growth Stock Around
Hims & Hers Health raised its guidance once again when it reported its Q3 results. The company saw significant growth in subscribers, particularly in the mental health and women's health sectors. H...
My 2024 Financial Resolution: Buying More of These 3 Stocks
SentinelOne keeps delivering cutting-edge tech and strong growth. Roku is an entrenched streaming leader with future growth ahead.
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs in the medical sector, led by the popularity of Ozempic. Celebrity usage and social media exposure have caused ...
Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Hims & Hers Health exhibits similarities to previous "100 Bagger" stocks, which I believe the market has not noticed at all. I wanted to bring this to the forefront. The company has the potential t...
Hims & Hers earnings highlight expanded personalized treatments
E-health and wellness platform operator Hims & Hers Inc. NASDAQ: HIMS reported a stellar quarter of growth. The company has expanded its medical offerings well beyond offering discrete erectile dys...
2 No-Brainer Stocks to Buy Right Now for Less Than $50
Well-chosen stocks can help you build lasting wealth. Read on to see how you could profit from the AI boom, as well as the shift toward more personalized healthcare.
Related Companies